Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0115716 (Stage IIIB Lung Non-Small Cell Cancer AJCC v7)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02595866Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant NeoplasmsTreatment